Niklas Selfjord

5PUBLICATIONS
33CO-AUTHORS
Molecular targetsPowder and particle technologyMedical devicesGene and molecular therapyMolecular evolution
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 26, 2026
Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomes.

|May 09, 2025
Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems.

Louis C Dacquay, Panagiotis Antoniou, Astrid Mentani

|Feb 10, 2025
Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy.

Sikai Ling, Xue Zhang, Yao Dai

|Nov 07, 2024
Engineered PsCas9 enables therapeutic genome editing in mouse liver with lipid nanoparticles.

Dmitrii Degtev, Jack Bravo, Aikaterini Emmanouilidi

|Sep 06, 2023
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo.

Burcu Bestas, Sandra Wimberger, Dmitrii Degtev

Pageof 1

Frequent Collaborators

4 joint publications

Marcello Maresca

3 joint publications

Pinar Akcakaya

2 joint publications

Sandra Wimberger

2 joint publications

Alexandra Madsen